Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 13.25
-0.75 (-5.36%)
Aug 22, 2025, 6:10 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 15.06 million as of August 22, 2025. Its market cap has increased by 417.75% in one year.
Market Cap
15.06M
Enterprise Value
14.65M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.25
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 15.06M, a decrease of -44.80%. That is a compound annual growth rate of -7.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | 31.54M | 81.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.71B |
| GSK plc | 59.74B |
| Haleon | 33.11B |
| Smith & Nephew | 12.13B |
| ConvaTec Group | 4.99B |
| Hikma Pharmaceuticals | 4.01B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 2.03B |